This inventor holds 1 USPTO granted patent. Top assignees: Merck Sharp + Dohme B.v., Merck Sharp + Dohme Corp.. Active years: 2021.
Company Filing History:
1 out of 55 
1 out of 2,405 
Years Active: 2021
Title: David J Goldfarb: Innovator in Pharmaceutical Formulations
Introduction
David J Goldfarb is a notable inventor based in Highland Park, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for injectable drug products. His work has implications for the treatment and prevention of serious health conditions, including HIV and AIDS.
Latest Patents
Goldfarb holds a patent for a formulation designed for parenteral administration. This innovative formulation provides a long-acting injectable drug product comprising a suspension of doravirine. The drug can be administered via intramuscular or subcutaneous routes, offering a new option for the treatment or prophylaxis of HIV infection, as well as for managing AIDS and AIDS-related complex.
Career Highlights
Throughout his career, Goldfarb has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corp. and Merck Sharp & Dohme B.V. His experience in these organizations has allowed him to contribute to the advancement of medical treatments and drug formulations.
Collaborations
Goldfarb has collaborated with talented professionals in his field, including Sachin Mittal and Irina Kazakevich. These partnerships have fostered innovation and have been instrumental in the development of his patented formulations.
Conclusion
David J Goldfarb is a distinguished inventor whose work in pharmaceutical formulations has the potential to impact the treatment of HIV and AIDS significantly. His contributions to the field exemplify the importance of innovation in healthcare.